Internal Medicine, Pulmonary Disease · Bakersfield, CA
NPI
1073541512
Since 2006
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
2
Medicare group memberships
Hospitals
3
Hospital affiliations
2901 Sillect Ave, Suite 202
Bakersfield, CA, 93308
Phone (661) 324-7300
Groups this clinician bills Medicare through
Medicare paid, 2024
$581K
11,147 services
Medicare patients, 2024
840
Average age 73
Drug cost, 2024
$4.0M
14,982 prescriptions
Company payments, 2025
$946
From 18 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Syed Alam was code 99454 (e&m - miscellaneous), 1,802 times for 238 patients. In total Syed Alam billed 11,147 services in 50 codes, and Medicare paid $581K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-11-15.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99454 E&M - Miscellaneous | Office | 1,802 | 238 | $38.84 | $70K |
| 99457 E&M - Miscellaneous | Office | 1,696 | 246 | $39.08 | $66K |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 1,651 | 220 | $48.75 | $80K |
| 99215 Office E&M - Established | Office | 721 | 485 | $135.40 | $98K |
| 99213 Office E&M - Established | Office | 651 | 463 | $60.69 | $40K |
| 99214 Office E&M - Established | Office | 529 | 416 | $103.21 | $55K |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 483 | 143 | $0.67 | $325 |
| 99458 E&M - Miscellaneous | Office | 471 | 128 | $31.14 | $15K |
| 94060 Pulmonary Function Testing | Office | 426 | 390 | $28.78 | $12K |
| 94729 Pulmonary Function Testing | Office | 416 | 381 | $43.20 | $18K |
| 94726 Pulmonary Function Testing | Office | 411 | 376 | $43.63 | $18K |
| 96372 Injection Administration | Office | 405 | 206 | $11.19 | $4,534 |
| 99439 Chronic, Principal, and Transitional Care Management | Office | 351 | 130 | $38.62 | $14K |
| 99291 Critical Care E&M | Facility | 253 | 89 | $165.02 | $42K |
| J1885 Injection, ketorolac tromethamine, per 15 mg | Office | 175 | 79 | $0.45 | $78.96 |
By year: 2022 $394K for 8,136 services; 2023 $399K for 9,359 services; 2024 $581K for 11,147 services.
Lab tests billed to Medicare, 2023
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 87637 Infectious Agent Detection by DNA/RNA | 14 | 14 | $139.78 | $1,957 |
Medicare prescription drug claims, 2024
In 2024, the drug Syed Alam prescribed most often to Medicare patients was Montelukast Sodium, with 1,757 prescriptions and refills. In total Syed Alam wrote 14,982 Medicare prescriptions that cost $4.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Montelukast Sodium Generic | 1,757 | 2,942 | 374 | $14K |
| Albuterol Sulfate Hfa Albuterol Sulfate | 529 | 567 | 161 | $15K |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 506 | 631 | 107 | $384K |
| Levothyroxine Sodium Generic | 479 | 948 | 97 | $4,459 |
| Atorvastatin Calcium Generic | 396 | 781 | 86 | $2,882 |
| Levocetirizine Dihydrochloride Generic | 365 | 580 | 117 | $5,951 |
| Gabapentin Generic | 351 | 456 | 62 | $2,595 |
| Fluticasone Propionate Generic | 325 | 485 | 86 | $3,049 |
| Amlodipine Besylate Generic | 322 | 685 | 71 | $1,681 |
| Losartan Potassium Generic | 277 | 551 | 59 | $1,904 |
| Omeprazole Generic | 273 | 512 | 58 | $2,438 |
| Desloratadine Generic | 272 | 410 | 70 | $8,375 |
| Metformin Hcl Generic | 266 | 491 | 57 | $1,511 |
| Ipratropium Bromide Generic | 242 | 352 | 92 | $7,637 |
| Tamsulosin Hcl Generic | 238 | 402 | 46 | $2,637 |
Brand drugs: 2,667 claims; generic drugs: 12,283 claims; opioid claims: 25.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Syed Alam $946 ($946 in general payments such as food, travel and fees) from 18 companies. The largest payer was GlaxoSmithKline, LLC. with $147.
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. GSK | 12 | $147 |
| Amgen Inc. AMGN | 12 | $136 |
| Insmed, Inc. INSM | 5 | $122 |
| Astellas Pharma US Inc 4503.T | 1 | $99.95 |
| Electromed, Inc. ELMD | 2 | $86.06 |
| AstraZeneca Pharmaceuticals LP AZN | 3 | $62.49 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $46.47 |
| Grifols USA, LLC | 2 | $38.85 |
| Merck Sharp & Dohme LLC MRK | 1 | $34.21 |
| Lilly USA, LLC LLY | 1 | $26.01 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.